Antioxidant therapies for obstructive sleep apnea: A systematic review and meta-analysis

Tarun Krishna Boppana1, Saurabh Mittal2, Karan Madan1

  • 1Department of Pulmonary, Critical Care, and Sleep Medicine, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, India, 110029.

Abstract

Insights

Antioxidant therapy significantly improves endothelial function and sleep quality in obstructive sleep apnea (OSA) patients. This approach reduces oxidative stress without adverse effects, suggesting potential for future clinical use.

Area of Science:

  • Cardiovascular Medicine
  • Sleep Medicine
  • Pharmacology

Background:

  • Obstructive sleep apnea (OSA) is linked to cardiovascular issues driven by oxidative stress and sympathetic overactivity.
  • Targeting oxidative stress is a potential therapeutic strategy for OSA management.

Purpose of the Study:

  • To systematically review and meta-analyze the efficacy and safety of antioxidant therapies in patients with OSA.

Main Methods:

  • Searched PubMed and Embase for human studies on antioxidant therapies in OSA patients.
  • Included six studies (five RCTs, one case-control) with 160 OSA patients.

Main Results:

  • Antioxidants significantly improved flow-mediated dilatation (FMD) by 2.16% (95% CI 1.65-2.67).
  • Reduced malondialdehyde and increased glutathione levels, indicating decreased oxidative stress.
  • Improved Epworth sleepiness scale, oxygen desaturation index, and minimum oxygen saturation without adverse effects.

Conclusions:

  • Antioxidant therapy enhances endothelial function, reduces oxidative stress, and improves sleep parameters in OSA.
  • Further multicenter studies with longer follow-up are warranted to confirm the utility of antioxidant therapy for OSA.

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
147
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
198
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
154